Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.antiviral.2020.104988

http://scihub22266oqcxt.onion/10.1016/j.antiviral.2020.104988
suck pdf from google scholar
33248195!7687369!33248195
unlimited free pdf from europmc33248195    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33248195      Antiviral+Res 2021 ; 185 (ä): 104988
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro #MMPMID33248195
  • Svenningsen EB; Thyrsted J; Blay-Cadanet J; Liu H; Lin S; Moyano-Villameriel J; Olagnier D; Idorn M; Paludan SR; Holm CK; Poulsen TB
  • Antiviral Res 2021[Jan]; 185 (ä): 104988 PMID33248195show ga
  • Pandemic spread of emerging human pathogenic viruses, such as the current SARS-CoV-2, poses both an immediate and future challenge to human health and society. Currently, effective treatment of infection with SARS-CoV-2 is limited and broad spectrum antiviral therapies to meet other emerging pandemics are absent leaving the World population largely unprotected. Here, we have identified distinct members of the family of polyether ionophore antibiotics with potent ability to inhibit SARS-CoV-2 replication and cytopathogenicity in cells. Several compounds from this class displayed more than 100-fold selectivity between viral-induced cytopathogenicity and inhibition of cell viability, however the compound X-206 displayed >500-fold selectivity and was furthermore able to inhibit viral replication even at sub-nM levels. The antiviral mechanism of the polyether ionophores is currently not understood in detail. We demonstrate, e.g. through unbiased bioactivity profiling, that their effects on the host cells differ from those of cationic amphiphiles such as hydroxychloroquine. Collectively, our data suggest that polyether ionophore antibiotics should be subject to further investigations as potential broad-spectrum antiviral agents.
  • |*COVID-19 Drug Treatment[MESH]
  • |Animals[MESH]
  • |Anti-Bacterial Agents/*pharmacology[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Chlorocebus aethiops[MESH]
  • |Ethers, Cyclic/*pharmacology[MESH]
  • |Humans[MESH]
  • |Ionophores/*pharmacology[MESH]
  • |SARS-CoV-2/*drug effects[MESH]
  • |Vero Cells[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box